Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Merit Medical Systems
MMSI
$5.2B
| $19.4M | 0.01% |
357,152
+18,826
| +6% | +$1.15M |
|
|
FRC
277
DELISTED
First Republic Bank
FRC
| $19.1M | 0.01% |
132,563
+16,275
| +14% | +$2.44M |
|
278
Amgen
AMGN
$219B
| $19M | 0.01% |
77,972
+1,358
| +2% | +$333K |
|
279
Century Aluminum
CENX
$4.67B
| $19M | 0.01% |
2,572,250
+62,681
| +2% | +$974K |
|
280
AeroVironment
AVAV
$8.55B
| $18.8M | 0.01% |
229,000
-12,157
| -5% | -$1.08M |
|
281
Ecopetrol
EC
$34.3B
| $18.6M | 0.01% |
1,714,870
+136,771
| +9% | +$2.18M |
|
282
Marvell Technology
MRVL
$192B
| $18.4M | 0.01% |
423,831
+105
| +0% | +$5.95K |
|
283
Oceaneering
OII
$4.85B
| $18.1M | 0.01% |
1,698,593
-3,482
| -0.2% | -$42.8K |
|
284
Veeco
VECO
$3.19B
| $18M | 0.01% |
926,177
-13,563
| -1% | -$301K |
|
285
Diodes
DIOD
$3.93B
| $17.9M | 0.01% |
277,638
+42
| +0% | +$3.06K |
|
286
Carpenter Technology
CRS
$28.7B
| $17.8M | 0.01% |
637,644
+22,191
| +4% | +$789K |
|
287
United Microelectronic
UMC
$48.3B
| $17.7M | 0.01% |
2,611,251
-346,832
| -12% | -$2.85M |
|
288
Kennametal
KMT
$2.7B
| $17.7M | 0.01% |
759,950
+75,186
| +11% | +$1.98M |
|
289
Emergent Biosolutions
EBS
$391M
| $16.8M | 0.01% |
541,789
+56,002
| +12% | +$1.91M |
|
290
Equinor
EQNR
$91.7B
| $16.6M | 0.01% |
476,847
+2,192
| +0.5% | +$78.3K |
|
291
Patterson-UTI
PTEN
$3.74B
| $16.6M | 0.01% |
1,050,450
+105,494
| +11% | +$1.77M |
|
292
Texas Capital Bancshares
TCBI
$4.37B
| $15.6M | 0.01% |
297,266
+20,370
| +7% | +$1.09M |
|
293
Piper Sandler
PIPR
$5.13B
| $15.5M | 0.01% |
545,676
+63,888
| +13% | +$1.93M |
|
294
D.R. Horton
DHI
$42.3B
| $15.4M | 0.01% |
233,409
+10,338
| +5% | +$727K |
|
295
IPG Photonics
IPGP
$4.01B
| $15.3M | 0.01% |
162,346
+9,407
| +6% | +$930K |
|
296
Viavi Solutions
VIAV
$9.85B
| $15.2M | 0.01% |
1,146,945
+100,930
| +10% | +$1.45M |
|
|
TPH
297
DELISTED
Tri Pointe Homes
TPH
| $15.1M | 0.01% |
893,849
+56,617
| +7% | +$1.11M |
|
298
Simpson Manufacturing
SSD
$8.12B
| $14.8M | 0.01% |
147,242
+7,654
| +5% | +$795K |
|
299
United Parcel Service
UPS
$91.7B
| $14.6M | 0.01% |
79,775
+293
| +0.4% | +$53.4K |
|
300
ResMed
RMD
$32.3B
| $14.5M | 0.01% |
69,078
+1,476
| +2% | +$314K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.